Purchases and Sales Made in Q4 2023 in Outlook Therapeutics, Inc. (OTLK)
This table provides information about the institutional ownership of Outlook Therapeutics, Inc. (OTLK) during Q4 2023. The information is specifically focused on institutions that hold shares of Outlook Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-23.7K- 50.74% |
$5.2K - $15.6K
|
23K
$168K
|
|
Feb 12, 2024
Q4 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-26.5K- 39.5% |
$5.82K - $17.5K
|
40.5K
$297K
|
|
Feb 12, 2024
Q4 2023
|
Scotia Capital Inc.
|
SELL
|
- |
-54.4K- 16.06% |
$12K - $35.9K
|
284K
$2.08M
|
|
Feb 14, 2024
Q4 2023
|
Captrust Financial Advisors
Raleigh, NC |
SELL
|
- |
-60K- 44.07% |
$13.2K - $39.6K
|
76.1K
$557K
|
|
Feb 06, 2024
Q4 2023
|
Lincoln National Corp
|
SELL
|
- |
-257K- 80.24% |
$56.5K - $170K
|
63.3K
$463K
|